These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4138501)

  • 1. Plethysmographical and clinical observations on Bricanyl therapy in Raynaud's phenomenon.
    Zabel J; Fyrand O; Thune P
    Acta Derm Venereol; 1974; 54(5):391-5. PubMed ID: 4138501
    [No Abstract]   [Full Text] [Related]  

  • 2. Further observations on the therapy with a beta-stimulating agent in Raynaud's phenomenon.
    Thune P; Fyrand O
    Acta Chir Scand Suppl; 1976; 465():84-6. PubMed ID: 793267
    [No Abstract]   [Full Text] [Related]  

  • 3. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment.
    Kumar N; Griffiths B; Allen J
    J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raynaud's symptoms in circumscript scleroderma].
    Korting GW; Brachtel R
    Hautarzt; 1972 Jun; 23(6):273-5. PubMed ID: 5054373
    [No Abstract]   [Full Text] [Related]  

  • 5. Skin temperature changes in Raynaud's disease after griseofulvin.
    Charles CR; Carmick ES
    Arch Dermatol; 1970 Mar; 101(3):331-6. PubMed ID: 5414890
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of Panergon therapy in Raynaud syndrome within the scope of progressive scleroderma].
    Bosmanský K; Tauchmannová H; Lukác J; Zitnan D
    Z Rheumatol; 1985; 44(5):242-5. PubMed ID: 4082792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of evaluating Raynaud's phenomenon for the purpose of pharmacotherapeutic research.
    Wouda AA
    Vasa Suppl; 1987; 18():32-9. PubMed ID: 3474798
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
    Goebel KM; Neitzert A
    Ther Umsch; 1975 Jun; 32(6):350-6. PubMed ID: 806127
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
    Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
    Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary biliary cirrhosis associated with CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia). Effect of cytostatic therapy in a case of our observation].
    Amoroso A; Di Rosa R; Afeltra A; Bolognesi A; Ferri GM; Bonomo L
    Recenti Prog Med; 1988 Apr; 79(4):169-72. PubMed ID: 3393727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subcutaneous calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia (CRST syndrome): an association of interest in hepatology (author's transl)].
    Dubois A; Jourdan J; Blotman F; Balmes JL; Janbon F; Bertrand A; Michel H
    Gastroenterol Clin Biol; 1978 Oct; 2(10):805-9. PubMed ID: 729977
    [No Abstract]   [Full Text] [Related]  

  • 12. [The thermoregulatory effectiveness of calcitonin in progressive scleroderma].
    Gevatter M; Keller J; Hornstein OP
    Z Hautkr; 1989 Jun; 64(6):507-10. PubMed ID: 2669402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pterygium inversum unguis-like changes in scleroderma. Report of four cases.
    Patterson JW
    Arch Dermatol; 1977 Oct; 113(10):1429-30. PubMed ID: 911171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Terbutaline (Bricanyl). A comparative investigation of the bronchodilating effects of oral terbutaline and orciprenaline].
    Wiggers S
    Ugeskr Laeger; 1973 Jul; 135(29):1526-8. PubMed ID: 4598197
    [No Abstract]   [Full Text] [Related]  

  • 15. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
    Pistorius MA; Planchon B; de Faucal P
    Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the Doppler-pulse volume recorder in Raynaud's phenomenon].
    Sciannameo F; Tazza D; Alberti D; Marianeschi P; Cao PG; Francucci M
    Arch Sci Med (Torino); 1983; 140(4):353-6. PubMed ID: 6673699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnostic considerations in Raynaud's phenomenon].
    Wollersheim H; Thien T
    Ned Tijdschr Geneeskd; 1986 Mar; 130(9):385-8. PubMed ID: 3960184
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of Raynaud's phenomenon by methyldopa.
    Varadi DP; Lawrence AM
    Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS; Gilgor RS; Allen LM; Duvic M
    Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.